OSPRI
Mckinney
About OSPRI
OSPRI is updating the infectious illness testing plan. Established by the combination of Community Direct DX, Scienetix, and the R&D section of Advanta Genetics, OSPRI is among the first molecular testing platforms in the world to be entirely vertically integrated.
Company Facts
- Operating status: Active
- IPO status: Private
- Employees: 11 – 50
- Total funding: $30.0M
- Last round: Series Unknown (Aug 2025)
- Website: ospribio.com
- Phone: 972.860.9659
Industries & Categories
Biotechnology, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/ospri-55919 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.